03:17 AM EDT, 08/12/2024 (MT Newswires) -- Michael Thomas Henderson, Director, Chief Executive Officer, on August 07, 2024, sold 40,000 shares in Apogee Therapeutics ( APGE ) for $1,624,764. Following the Form 4 filing with the SEC, Henderson has control over a total of 1,434,487 shares of the company, with 1,434,487 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1974640/000110465924087939/xslF345X03/tm2421174-1_4seq1.xml